Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
주식 순위 #32096
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
주가
$0.21483059
마지막 동기화: 2024-05-07
시가총액
$11.13M
변동 (1일)
0.34%
변동 (1년)
0.00%
국가
CA
거래 Antibe Therapeutics Inc. (ATE)

카테고리

Antibe Therapeutics Inc. (ATE)의 주식 분할 이력
Antibe Therapeutics Inc. 주식 (심볼: ATE)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 18, 2026에 발생했습니다.
Aug 18, 2026 이전에 매수한 ATE 주식 1주는 현재 0주의 ATE 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
9 x285
US
9 x162
US
7 x127
IE
2 x4
US
3 x12
US